Human osteogenesis involves differentiation-dependent increases in the morphogenically active 3' alternative splicing variant of acetylcholinesterase

Molecular and Cellular Biology

Volumn 19, Issue 1, 1999, Pages 788-795

  Grisaru, Dan ^a,b   Lev Lehman, Efrat ^a,d   Shapira, Michael ^a   Chaikin, Ellen ^a   Lessing, Joseph B ^b   Eldor, Amiram ^b   Eckstein, Fritz ^c   Soreq, Hermona ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c MAX PLANCK INSTITUTE OF EXPERIMENTAL MEDICINE   (Germany)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINESTERASE;

ARTICLE; BINDING SITE; BONE DEVELOPMENT; CELL DIFFERENTIATION; CELL PROLIFERATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; RNA SPLICING;

EID: 0032913474     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.19.1.788     Document Type: Article

References (43)

1. Alber, R., O. Sporns, T. Weikert, E. Willbold, and P. G. Layer. 1994. Cholinesterases and peanut agglutinin binding related to cell proliferation and axonal growth in embryonic chick limbs. Anat. Embryol. (Berlin) 190:429-438.
2. Appleyard, M. E., and B. McDonald. 1991. Reduced adrenal gland acetylcholinesterase activity in Alzheimer's disease. Lancet 338:1085-1086. (Letter.)
3. Aubin, J. E., F. Liu, L. Malaval, and K. Gupta. 1995. Osteoblast and chondroblast differentiation. Bone 17:77S-83S.
4. Auld, V. J., R. D. Fetter, K. Broadie, and C. S. Goodman. 1995. Gliotactin, a novel transmembrane protein on peripheral glia, is required to form the blood-nerve barrier in Drosophila. Cell 81:757-767.
5. Ben Aziz-Aloya, R., S. Seidman, R. Timberg, M. Sternfeld, H. Zakut, and H. Soreq. 1993. Expression of a human acetylcholinesterase promoter-reporter construct in developing neuromuscular junctions of Xenopus embryos. Proc. Natl. Acad. Sci. USA 90:2471-2475.
6. Boskey, A. L. 1981. Current concepts of the physiology and biochemistry of calcification. Clin. Orthop. 157:225-257.
7. Brank, M., K. Zajc-Kreft, S. Kreft, R. Komel, and Z. Grubic. 1998. Biogenesis of acetylcholinesterase is impaired, although its mRNA level remains normal, in the glucocorticoid-treated rat skeletal muscle. Eur. J. Biochem. 251:374-381.
8. Brenner, R. F., A. Nerlich, R. Terinde, and P. Bartmann, 1996. In vitro studies on clonal growth of chondrocytes in thanatophoric dysplasia. Am. J. Med. Genet. 63:401-405.
9. Bruder, S. P., D. J. Fink, and A. I. Caplan. 1994. Mesenchymal stem cells in bone development, bone repair, and skeletal regeneration therapy. J. Cell. Biochem. 56:283-294.
10. Candeliere, G. A., P. W. Jurutka, M. R. Haussler, and R. St-Arnaud. 1996. A composite element binding the vitamin D receptor, retinoid X receptor α, and a member of the CTF/NF-1 family of transcription factors mediates the vitamin D responsiveness of the c-fos promoter. Mol. Cell. Biol. 16:584-592.
11. Darboux, I., Y. Barthalay, M. Piovant, and R. Hipeau-Jacquotte. 1996. The structure-function relationships in Drosophila neurotactin show that cholinesterasic domains may have adhesive properties. EMBO J. 15:4835-4843.
12. de la Escalera, S., E. O. Bockamp, F. Moya, M. Piovant, and F. Jimenez. 1990. Characterization and gene cloning of neurotactin, a Drosophila transmembrane protein related to cholinesterases. EMBO J. 9:3593-3601.
13. Delezoide, A. L., C. Lasselin-Benoist, L. Legeai-Mallet, P. Brice, V. Senee, A. Yayon, A. Munnich, M. Vekemans, and J. Bonaventure. 1997. Abnormal FGFR 3 expression in cartilage of thanatophoric dysplasia fetuses. Hum. Mol. Genet. 6:1899-1906.
14. Dukas, K., P. Sarfati, N. Vaysse, and L. Pradayrol. 1993. Quantitation of changes in the expression of multiple genes by simultaneous polymerase chain reaction. Anal. Biochem. 215:66-72.
15. Ehrlich, G., D. Patinkin, D. Ginzberg, H. Zakut, F. Eckstein, and H. Soreq. 1994. Use of partially phosphorothioated "antisense" oligonucleotides for sequence-dependent modulation of hematopoiesis in culture. Antisense Res. Dev. 4:173-183.
16. Eriksen, E. F., D. S. Colvard, N. J. Berg, M. L. Graham, K. G. Mann, T. C. Spelsberg, and B. L. Riggs. 1988. Evidence of estrogen receptors in normal human osteoblast-like cells. Science 241:84-86.
17. Ernst, M., C. Schmid, and E. R. Froesch. 1988. Enhanced osteoblast proliferation and collagen gene expression by estradiol. Proc. Natl. Acad. Sci. USA 85:2307-2310.
18. Grifman, M., and H. Soreq. 1997. Differentiation intensifies the susceptibility of pheochromocytoma cells to antisense oligodeoxynucleotide-dependent suppression of acetylcholinesterase activity. Antisense Nucleic Acid Drug Dev. 7:351-359.
19. Huong, P. L., A. H. Kolk, T. A. Eggelte, C. P. Verstijnen, H. Gilis, and J. T. Hendriks. 1991. Measurement of antigen specific lymphocyte proliferation using 5-bromo-deoxyuridine incorporation. An easy and low cost alternative to radioactive thymidine incorporation. J. Immunol. Methods 140:243-248.
20. Ichtchenko, K., T. Nguyen, and T. C. Sudhof. 1996. Structures, alternative splicing, and neurexin binding of multiple neuroligins. J. Biol. Chem. 271: 2676-2682.
21. Karpel, R., R. Ben Aziz-Aloya, M. Sternfeld, G. Ehrlich, D. Ginzberg, P. Tarroni, F. Clementi, H. Zakut, and H. Soreq. 1994. Expression of three alternative acetylcholinesterase messenger RNAs in human tumor cell lines of different tissue origins. Exp. Cell Res. 210:268-277.
22. Karpel, R., M. Sternfeld, D. Ginzberg, E. Guhl, A. Graessmann, and H. Soreq. 1996. Overexpression of alternative human acetylcholinesterase forms modulates process extensions in cultured glioma cells. J. Neurochem. 66:114-123.
23. Kaufer, D., A. Friedman, S. Seidman, and H. Soreq. 1998. Acute stress facilitates long-lasting changes in cholinergic gene expression. Nature 393: 373-377.
24. Komm, B. S., C. M. Terpening, D. J. Benz, K. A. Graeme, A. Gallegos, M. Kore, G. L. Greene, B. W. O'Malley, and M. R. Hausler. 1988. Estrogen binding, receptor mRNA, and biologic response in osteoblast-like osteosarcoma cells. Science 241:81-84.
25. Komori, T., H. Yagi, S. Nomura, A. Yamaguchi, K. Sasaki, K. Deguchi, Y. Shimizu, R. T. Bronson, Y. H. Gao, M. Inada, M. Sato, R. Okamoto, Y. Kitamura, S. Yoshiki, and T. Kishimoto. 1997. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturation arrest of osteoblasts. Cell 89:755-764.
26. Layer, P. G., and E. Willbold. 1995. Novel functions of cholinesterases in development, physiology and disease. Prog. Histochem. Cytochem. 29:1-94.
27. Lemaire, P., C. Vesque, J. Schmitt, H. Stunnenberg, R. Frank, and P. Charnay. 1990. The serum-inducible mouse gene Krox-24 encodes a sequence-specific transcriptional activator. Mol. Cell. Biol. 10:3456-3467.
28. Lev-Lehman, E., V. Deutsch, A. Eldor, and H. Soreq. 1997. Immature human megakaryocytes produce nuclear-associated acetylcholinesterase. Blood 89: 3644-3653.
29. Lev-Lehman, E., D. Ginzberg, G. Hornreich, G. Ehrlich, A. Meshorer, F. Eckstein, H. Soreq, and H. Zakut. 1994. Antisense inhibition of acetylcholinesterase gene expression causes transient hematopoietic alterations in vivo. Gene Ther. 1:127-135.
30. 3 receptor and other nonreceptor transcription factors. Mol. Endocrinol. 8:1593-1604.
31. 3 enhancement of osteopontin gene expression. Bone 20:329-334.
32. Moore, J. W., G. M. G. Clark, O. Takatani, Y. Wakabayashi, J. L. Hayward, and R. D. Bulbrook. 1983. Distribution of 17 beta-estradiol in the sera of normal British and Japanese women. J. Natl. Cancer Inst. 71:749-755.
33. Oliver, M. H., N. K. Harrison, J. E. Bishop, P. J. Cole, and G. J. Laurent. 1989. A rapid and convenient assay for counting cells cultured in microwell plates: application for assessment of growth factors. J. Cell Sci. 92:513-518.
34. Quandt, K., K. Frech, H. Karas, E. Wingender, and T. Werner. 1995. MatInd and MatInspector - new fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res. 23:4878-4884.
35. Seidman, S., M. Sternfeld, R. Ben Aziz-Aloya, R. Timberg, D. Kaufer-Nachum, and H. Soreq. 1995. Synaptic and epidermal accumulations of human acetylcholinesterase are encoded by alternative 3′-terminal exons. Mol. Cell. Biol. 15:2993-3002.
36. Seidman, S., R. Ben Aziz-Aloya, R. Timberg, Y. Loewenstein, B. Velan, A. Shafferman, J. Liao, B. Norgaard-Pedersen, U. Brodbeck, and H. Soreq. 1994. Overexpressed monomeric human acetylcholinesterase induces subtle ultrastructural modifications in developing neuromuscular junctions of Xenopus laevis embryos. J. Neurochem. 62:1670-1681.
37. Shapira, M., M. Korner, L. Bosgraaf, I. Tur-Kaspa, and H. Soreq. The human ACHE locus includes a polymorphic enhancer domain 17 kb upstream from the transcription start site. In D. M. Quinn, B. P. Doctor, and P. Taylor (ed.), Cholinesterases and related proteins, in press. Plenum Press, New York, N.Y.
38. Sillence, D. O., W. A. Horton, and D. L. Rimoin. 1979. Morphologic studies in skeletal dysplasias. Am. J. Pathol. 96:813-859.
39. Soreq, H., D. Patinkin, E. Lev-Lehman, M. Grifman, D. Ginzberg, F. Eckstein, and H. Zakut. 1994. Antisense oligonucleotide inhibition of acetylcholinesterase gene expression induces progenitor cell expansion and suppresses hematopoietic apoptosis ex vivo. Proc. Natl. Acad. Sci. USA 91:7907-7911.
40. Sternfeld, M., G. Ming, H. Song, K. Sela, R. Timbers, M. Poo, and H. Soreq. 1998. Acetylcholinesterase enhances neurite growth and synapse development through alternative contributions of its hydrolytic capacity, core protein, and variable C termini. J. Neurosci. 18:1240-1249.
41. 3 metabolites in chondrocyte culture. J. Cell. Physiol. 157:271-278.
42. Tora, L., M. P. Gaub, S. Madar, A. Dierich, M. Bellard, and P. Chambon. 1988. Cell-specific activity of a GGTCA half-palindromic oestrogen-responsive element in the chicken ovalbumin gene promoter. EMBO J. 7:3771-3778.
43. Umezu, Y., N. Nagata, Y. Doi, H. Furukawa, T. Sagara, T. Hayashida, H. Ogata, and S. Fujimoto. 1993. Cytochemical and immunocytochemical demonstration of acetylcholinesterase of the prenatal rat lower limb. Arch. Histol. Cytol. 56:217-224.